Pathway | Overlap size | p-value (FDR = 5%) | |
---|---|---|---|
MPS IIIA | Vitamin B1 (thiamin) metabolism | 2 | 2.77E−03 |
Pyrimidine metabolism | 2 | 9.86E−03 | |
MPS IIIB | TCA cycle | 2 | 1.41E−03 |
Aspartate and asparagine metabolism | 4 | 1.81E−03 | |
Vitamin E metabolism | 3 | 3.00E−03 | |
Methionine and cysteine metabolism | 3 | 4.78E−03 | |
Fatty acid activation | 2 | 4.89E−03 | |
Lysine metabolism | 2 | 9.66E−03 | |
De novo fatty acid biosynthesis | 2 | 1.31E−02 | |
Tryptophan metabolism | 3 | 3.31E−02 | |
MPS IIIC | Vitamin B1 (thiamin) metabolism | 2 | 5.54E−04 |
Omega-3 fatty acid metabolism | 2 | 8.27E−04 | |
Butanoate metabolism | 2 | 1.71E−03 | |
Tryptophan metabolism | 3 | 8.07E−03 | |
Linoleate metabolism | 2 | 1.18E−02 | |
Tyrosine metabolism | 3 | 2.28E−02 | |
Methionine and cysteine metabolism | 2 | 2.60E−02 | |
MPS IIID | TCA cycle | 2 | 1.41E−03 |
Vitamin B1 (thiamin) metabolism | 2 | 1.41E−03 | |
Aspartate and asparagine metabolism | 4 | 3.08E−03 | |
Butanoate metabolism | 2 | 5.14E−03 | |
Carnitine shuttle | 2 | 2.32E−02 | |
Arginine–proline metabolism | 2 | 2.91E−02 | |
Tryptophan metabolism | 3 | 4.36E−02 |